Introduction to the themed collection on Covalent Drug Discovery
Abstract
A graphical abstract is available for this content
- This article is part of the themed collection: Covalent Drug Discovery
* Corresponding authors
a
Department of Biological Chemistry, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
E-mail:
kbackus@mednet.ucla.edu
b Department of Chemistry and Biochemistry, UCLA, Los Angeles, CA, USA
c
State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, School of Chemical Biology and Biotechnology, Shenzhen Graduate School, Peking University, Shenzhen 518055, China
E-mail:
panzy@pkusz.edu.cn
d Center for Protein Degradation, Dana-Farber Cancer Institute, Boston, MA, USA
e
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA
E-mail:
lyn_jones@dfci.harvard.edu
A graphical abstract is available for this content
K. M. Backus, Z. Pan and L. H. Jones, RSC Med. Chem., 2022, 13, 893 DOI: 10.1039/D2MD90022J
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content